Although challenges such as limited bioavailability and safety concerns continue to impede clinical translation, these limitations may be addressed through the optimization of delivery strategies, rigorous pharmacokinetic and toxicological assessments, mechanism-driven in vitro , in vivo , ex vivo studies, and well-designed clinical trials
doi:10.1080/07315724.2014.926153
Order now and join the 200,000+ people who trust ProHealth
Identification of sensor cysteines in human Keap1 modified by the cancer chemopreventive agent sulforaphane
NAD is crucial for normal development, survival, and function of energy-hungry tissues, like the brain, skeletal muscle, and liver